中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [17]
合肥物质科学研究院 [7]
过程工程研究所 [3]
长春光学精密机械与物... [1]
新疆理化技术研究所 [1]
自动化研究所 [1]
更多
采集方式
OAI收割 [31]
内容类型
期刊论文 [30]
学位论文 [1]
发表日期
2020 [31]
学科主题
筛选
浏览/检索结果:
共31条,第1-10条
帮助
限定条件
发表日期:2020
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy
期刊论文
OAI收割
NANO TODAY, 2020, 卷号: 35, 页码: 12
作者:
Zhang, Ling-xiao
;
Sun, Xia-mei
;
Jia, Ying-bo
;
Liu, Xiao-ge
;
Dong, Mingdong
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2021/03/29
Malignant cancer immunotherapy
Layered double hydroxide based nanovaccine
Vaccination routes
Quick induction of anti-tumor immunity
Efficient delivery of clay-based nanovaccines to the mouse spleen promotes potent anti-tumor immunity for both prevention and treatment of lymphoma
期刊论文
OAI收割
NANO RESEARCH, 2020, 页码: 9
作者:
  |  
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2021/03/29
cancer immunotherapy
nanovaccine
layered double hydroxide
targeted delivery to the spleen
lymphoma
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
期刊论文
OAI收割
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 卷号: 39
作者:
Ma, Liying
;
Bian, Xing
;
Lin, Wenchu
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/11/30
SCLC
PI3K
HDAC
CUDC-907
PARP1
Olaparib
DSB repair
Combination treatment
Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3
期刊论文
OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15
作者:
Selvaggi, G.
;
Wakelee, H. A.
;
Mok, T.
;
Wu, Y. -L.
;
Reck, M.
  |  
收藏
  |  
浏览/下载:128/0
  |  
提交时间:2020/11/30
ALK plus NSCLC
ensartinib
Crizotinib
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
期刊论文
OAI收割
LEUKEMIA, 2020
作者:
Yang, Yong
;
Wang, Ying
;
Liu, Xin
;
He, Xia
;
Zhang, Li-Ling
  |  
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2020/11/30
Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5
作者:
Liu, Juan
;
Liang, Qianmao
;
Wang, Aoli
;
Zou, Fengming
;
Qi, Ziping
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2020/11/30
Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:
Li, Cong
;
Lu, Fangxiao
;
Lei, Tao
;
Yu, Haifeng
;
Yang, Haiyan
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/11/30
B-cell lymphoma
chemotherapy
interstitial pneumonia (IP)
risk factor
rituximab
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10
作者:
Zhang, Xiao-tuan
;
Hu, Xiao-bei
;
Wang, Han-lin
;
Kan, Wei-juan
;
Xu, Lei
  |  
收藏
  |  
浏览/下载:74/0
  |  
提交时间:2020/12/24
DLBCL
BTK inhibitor
ibrutinib resistance
UPR
TUDCA
2-DG
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients
期刊论文
OAI收割
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020
作者:
Song, Zhengbo
;
Liu, Tianchi
;
Shi, Lei
;
Yu, Zongyang
;
Shen, Qing
  |  
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2020/10/26
Deep learning model
Anaplastic lymphoma kinase
Computed tomography
Non-small cell lung cancer
颗粒引入对传统乳液佐剂效应的影响
学位论文
OAI收割
: 中国科学院大学, 2020
作者:
邹勇娟
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2021/09/07
壳聚糖颗粒,水包油包颗粒乳液,Pickering乳液,颗粒乳液复合佐剂